Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06617312
PHASE2

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

This study will randomize 64 non-treatment seeking individuals who smoke cigarettes daily in a double-blind, placebo-controlled laboratory study testing the effects of cytisinicline on the neural substrates of cigarette cue reactivity.

Official title: Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-Reactivity

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2024-12-05

Completion Date

2026-12

Last Updated

2025-12-03

Healthy Volunteers

No

Interventions

DRUG

Cytisinicline

Targets α4β2 nicotinic acetylcholine receptors

DRUG

Placebo Oral Capsule

Matched to active drug, cytisinicline

Locations (1)

University of California Los Angeles

Los Angeles, California, United States